Navigation Links
UF researcher urges caution in reducing blood pressure in patients with diabetes, coronary disease
Date:3/14/2010

GAINESVILLE, Fla. For patients with diabetes and heart disease, less isn't always more at least when it comes to blood pressure.

New data show an increased risk of heart attack, stroke or death for patients having blood pressure deemed too high or too low, according to Rhonda Cooper-DeHoff, Pharm.D., an associate professor of pharmacy and medicine at UF. She reported her findings today (Sunday, March 14) at the American College of Cardiology's 59th annual scientific session in Atlanta.

She recommends raising the systolic bar above 120 for blood pressure in patients with diabetes and coronary artery disease, saying that levels between 130 and 140 appear to be the most healthful.

Based on hypertension treatment guidelines, health-care practitioners have assumed that with regard to blood pressure, "the lower, the better," Cooper-DeHoff said. But, The International Verapamil SR-Trandolapril study, known as INVEST, suggests that the range considered normal for healthy Americans may actually be risky for those with a combined diagnosis of diabetes and coronary artery disease.

"Our data suggest that in patients with both diabetes and coronary artery disease, there is a blood pressure threshold below which cardiovascular risk increases," Cooper-DeHoff said.

As many as two out of three adults with diabetes have high blood pressure. Normal blood pressure as defined by the American Heart Association is less than 120 systolic and less than 80 diastolic. Blood pressure greater than 140 is still associated with a nearly 50 percent increase in cardiovascular risk in patients with diabetes. But efforts to reduce systolic blood pressure to below 130 did not appear to offer any additional benefit to diabetics with coronary artery disease compared with reduction of systolic blood pressure to between 130 and less than 140.

Cooper-DeHoff's study reveals for the first time that this group of patients also had a similar increase in risk when their blood pressure was controlled to lower than 115 systolic the range recommended as normal by the American Heart Association.

Stephan Brietzke, M.D., an endocrinologist who did not participate in the research, was intrigued by the findings, saying that they parallel recent studies looking at blood sugar control, which suggest a U-shaped curve with higher cardiovascular risks at both "too high" and "too low" extremes.

Brietzke, an associate professor of clinical medicine at the University of Missouri-Columbia since 2002, led a multidisciplinary team that developed Veterans Health Administration and Department of Defense collaborative guidelines for the treatment of type 2 diabetes. He sees this as an important study for doctors treating patients with diabetes and cardiovascular disease.

"Identifying thresholds of when to initiate treatment, and when to say 'good enough,' is extremely important not only to optimize patient outcomes, but also to help reduce unnecessary costs of care," Brietzke said.

The AHA reports that heart disease or stroke is the top cause of death for people with diabetes, affecting more than 60 percent of patients. High blood pressure, common in diabetes, doubles the risk of cardiovascular disease.


'/>"/>

Contact: Linda Homewood
homewood@ufl.edu
352-665-3665
University of Florida
Source:Eurekalert

Related biology news :

1. Carnegie Mellon researchers seek to control blood loss
2. Clemson researcher receives grant to study engineering enrollment of women, minorities
3. U of Minnesota researcher discovers how electricity moves through cells
4. Researchers characterize stem cell function
5. Penn researchers identify immune cells that fight parasites may promote allergies and asthma
6. Boost ivory trade monitoring and enforcement before allowing one-off sales: UBC researcher
7. VAI researchers develop tool to help study prostate cancer
8. LSUHSC researcher finds first inherited prostate cancer genetic mutation in African-American men
9. Researchers examine plants ability to identify, block invading bacteria
10. Community involvement important in fight against childhood obesity, according to UTHealth researchers
11. Sorting device for analyzing biological reactions puts the power of a lab in a researcher’s pocket
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
Breaking Biology News(10 mins):
(Date:5/16/2017)... , ... May 16, 2017 ... ... the general availability of its new ProxiMeta™ Hi-C metagenomic deconvolution service. ProxiMeta ... affordably—without culturing or high-molecular-weight DNA extraction—speeding research insights at lower cost. , ...
(Date:5/16/2017)... 16, 2017 Telehealth has long been ... something that has been kept completely separate from ... according to   Logicalis Healthcare Solutions , the ... solutions and managed services provider ( www.us.logicalis.com ), ... – interrelationship between telehealth, imaging, and EHR optimization ...
(Date:5/15/2017)... PA (PRWEB) , ... May 15, 2017 , ... ... insights in a presentation of “The Key Role of Specifications in Process Validation,” at ... of Philadelphia . The event will bring together leaders from the pharmaceutical and biotech ...
(Date:5/15/2017)... ... May 15, 2017 , ... Continuing to ... skincare brand has today launched its first-ever cross-medium campaign, #StandFirm, with high-visibility social ... digital and social media channels, emphasizing Algenist’s stance on individuality and disruption: ...
Breaking Biology Technology: